# Somi Health reviews (2026): GLP-1 telehealth sellers | This GLP The seller states the flat-dose claim in its own capital letters, and prices its tablet at more than double the shot. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/somi-health Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 ANY DOSE, in capitals # Somi Health review The seller states the flat-dose claim in its own capital letters, and prices its tablet at more than double the shot. ## The verdict Somi Health publishes $135 a month for injected semaglutide on a three-month plan and $165 for tirzepatide. Both cards say ANY DOSE. The tablet is $279. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Dose pricing Flat across doses Injection From $135/mo Oral From $279/mo Prescription Required Compounded Yes — not FDA-approved Somi Health sells both molecules by injection and semaglutide as a tablet. The injections are priced by plan length. The tablet has one published plan. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages price plans rather than describe care. No clinician is named. Stating the dose claim in capitals is unusual and useful. It leaves no room to argue the figure was a starting rate. 2. ## What happens when the dose goes up? ANY DOSE is the whole answer, given plainly on both injection cards. Nothing states what the tablet does at a higher strength. 3. ## What the price includes Six months of injected semaglutide is $810 and tirzepatide $990, on the three-month plans. The tablet costs $279 a month, which is more than double the injection it replaces. Only the one-month tablet plan is published. 4. ## What it claims, and what it cites All three lines are compounded. A pharmacy makes them to order. No agency reviews them before they ship. ## Where it holds up, and where it does not - Strength: The flat-dose claim is stated emphatically - Strength: Both injections priced by plan length - Strength: A tablet route exists and is priced - Limitation: The tablet costs more than double the shot - Limitation: Only one tablet plan is published - Limitation: No milligram appears on any card - Limitation: Nothing lists the states served ## What the evidence says about this kind of treatment The assessment above is about Somi Health. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants the dose question answered in writing before anything else. Wrong for A reader hoping the tablet is the cheaper way in here. ## The evidence behind what Somi Health prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Somi Health compares | Seller | Who it suits | Go | | --- | --- | --- | | Silhouette MD | Readers who want an unqualified number and will pay the tablet premium for one | | | Auren Rx | Readers who want a cancel-anytime subscription with the no-commitment rate printed beside it | | | Pepton Health | Readers who will create an account before deciding anything | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Voxy](https://thisglp.com/reviews/voxy) [Vyora Wellness](https://thisglp.com/reviews/vyora-wellness) [VyrarX](https://thisglp.com/reviews/vyrarx) [Vytora Health](https://thisglp.com/reviews/vytora-health) [Walgreens Weight Management](https://thisglp.com/reviews/walgreens-weight-management) [WeightCare](https://thisglp.com/reviews/weightcare) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Does the price change with the dose? No. Both injection cards say ANY DOSE, in the seller's own capitals. What does the tablet cost? $279 a month, on the only tablet plan published. What does six months come to? $810 for semaglutide and $990 for tirzepatide on the three-month plans. Is Somi Health expensive compared with other GLP-1 telehealth sellers? Somi Health publishes a starting figure of $135/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Somi Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).